Prior work led by Elizabeth Jaffee, M.D., deputy director of the Kimmel Cancer Center, and Azad, found that the drug entinostat—an HDACi known to modify gene expression patterns—altered the ...
Syndax Pharmaceuticals has announced a new collaboration with Roche’s Genentech unit dedicated to combining small molecule cancer drug entinostat with the latter’s immunotherapy, Tecentriq.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback